
Ami Aalok Shah MD MHS
Professor of Medicine, Johns Hopkins University School of Medicine; Director, Division of Rheumatology; Co-Director, Johns Hopkins Scleroderma Center
Join to View Full Profile
5501 Hopkins Bayview CircleBaltimore, MD 21224
Phone+1 443-997-1552
Fax+1 410-550-1033
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2007 - 2009
- Johns Hopkins UniversityFellowship, Rheumatology, 2006 - 2009
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2006
- Johns Hopkins University School of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2020 - Present
- CA State Medical License 2004 - 2026
- MD State Medical License 2009 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2019 Jun 26
Publications & Presentations
PubMed
- Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.Ali Y Ayla, Naveen R Kalavar, Mark Pimentel, Walter Morales, Laura K Hummers
Rheumatology. 2025-04-12 - Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.Yiming Luo, Shervin Assassi, Maureen D Mayes, Tracy M Frech, Virginia D Steen
Annals of the American Thoracic Society. 2025-04-10 - Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis.Elise F Gray-Gaillard, Ami A Shah, Clifton O Bingham Iii, Jennifer H Elisseeff, Joseph Murray
Arthritis Research & Therapy. 2025-04-01
Journal Articles
- Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal DysmotilityRobyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research
Press Mentions
- Anti-SSSCA1 Positivity Tied to Cancer Risk in SSc PatientsFebruary 12th, 2022
- Autoantibodies Could Help Predict Cancer Risk in SclerodermaAugust 6th, 2023
Professional Memberships
- Member
- Fellow
Other Languages
- Gujarati
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ami-shah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: